Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,384 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Belotecan/cisplatin versus etoposide/cisplatin in previously untreated patients with extensive-stage small cell lung carcinoma: a multi-center randomized phase III trial.
Oh IJ, Kim KS, Park CK, Kim YC, Lee KH, Jeong JH, Kim SY, Lee JE, Shin KC, Jang TW, Lee HK, Lee KY, Lee SY. Oh IJ, et al. Among authors: kim sy, kim ks, kim yc. BMC Cancer. 2016 Aug 26;16(1):690. doi: 10.1186/s12885-016-2741-z. BMC Cancer. 2016. PMID: 27566413 Free PMC article. Clinical Trial.
A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401.
Oh IJ, Kim KS, Kim YC, Ban HJ, Kwon YS, Kim YI, Lim SC, Chung WK, Nam TK, Song JY, Yoon MS, Ahn SJ. Oh IJ, et al. Among authors: kim yi, kim ks, kim yc. Cancer Chemother Pharmacol. 2013 Dec;72(6):1247-54. doi: 10.1007/s00280-013-2308-5. Epub 2013 Oct 5. Cancer Chemother Pharmacol. 2013. PMID: 24091849 Clinical Trial.
Randomized Phase III Study of Docetaxel Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-line Treatment of Nonsquamous Non-Small-cell Lung Cancer: A TRAIL Trial.
Park CK, Oh IJ, Kim KS, Choi YD, Jang TW, Kim YS, Lee KH, Shin KC, Jung CY, Yang SH, Ryu JS, Jang SH, Yoo SS, Yong SJ, Lee KY, In KH, Lee MK, Kim YC. Park CK, et al. Among authors: kim ks, kim ys, kim yc. Clin Lung Cancer. 2017 Jul;18(4):e289-e296. doi: 10.1016/j.cllc.2017.01.002. Epub 2017 Jan 11. Clin Lung Cancer. 2017. PMID: 28185792 Clinical Trial.
Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: a korean Lung Cancer Registry Study.
In KH, Kwon YS, Oh IJ, Kim KS, Jung MH, Lee KH, Kim SY, Ryu JS, Lee SY, Jeong ET, Lee SY, Yum HK, Lee CG, Kim WS, Zo JI, Kim H, Kim YW, Kim SK, Lee JC, Kim YC. In KH, et al. Among authors: kim h, kim sy, kim ks, kim sk, kim yc, kim ws, kim yw. Lung Cancer. 2009 May;64(2):232-7. doi: 10.1016/j.lungcan.2008.08.005. Epub 2008 Sep 21. Lung Cancer. 2009. PMID: 18809225
6,384 results